Submitted by Anonymous (not verified) on 5 November 2025 - 16:00
Human medicines European public assessment report (EPAR): Pylclari, piflufolastat (18F), Date of authorisation: 27/11/2023, Revision: 7, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Pylclari, piflufolastat (18F), Date of authorisation: 27/11/2023, Revision: 7, Status: Authorised